Literature DB >> 20202301

Are the statistical data from Benin's National Tuberculosis Programme reliable?

A Trébucq1, J P Zellweger, F Kassa, K Lambregts, M Gninafon.   

Abstract

SETTING: The National Tuberculosis Programme (NTP) of Benin, West Africa.
OBJECTIVE: To verify the accuracy of the data published by the NTP in terms of notified cases and treatment results.
DESIGN: Purposeful selection of nine basic management units (BMUs) that had declared zero tuberculosis (TB) patients lost to follow-up in the first three quarters of 2006. Retrospective onsite survey by independent teams based on the documents kept at the BMUs, on the data transmitted to and compiled at the central level and on home interviews with patients who had been declared treatment successes.
RESULTS: Of the 446 cases evaluated, there was excellent agreement between the TB register and the TB treatment card, between the TB register and the quarterly reports and between the TB register and the laboratory register. Home interviews with 32 patients all confirmed the information contained in the treatment cards and the TB register.
CONCLUSION: The results published by the NTP of Benin are remarkably reliable.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202301

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  2 in total

1.  Follow-up and tracing of tuberculosis patients who fail to attend their scheduled appointments in Cotonou, Benin: a retrospective cohort study.

Authors:  Serge Ade; Arnaud Trébucq; Anthony D Harries; Gabriel Ade; Gildas Agodokpessi; Prudence Wachinou; Dissou Affolabi; Sévérin Anagonou
Journal:  BMC Health Serv Res       Date:  2016-01-11       Impact factor: 2.655

2.  A care pathway analysis of tuberculosis patients in benin: Highlights on direct costs and critical stages for an evidence-based decision-making.

Authors:  Samia Laokri; Arnaud Amoussouhui; Edgard M Ouendo; Athanase Cossi Hounnankan; Séverin Anagonou; Martin Gninafon; Ferdinand Kassa; Léon Tawo; Bruno Dujardin
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.